Quick Answer
Bone Biologics Corp reported Stockholders Equity of $5.38 million for fiscal year 2025.
Bone Biologics Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.38M | +54.4% |
| 2024 | $3.48M | +19.9% |
| 2023 | $2.91M | -51.1% |
| 2022 | $5.95M | -9.6% |
| 2021 | $6.58M | +148.0% |
| 2020 | -$13.69M | -15.4% |
| 2019 | -$11.87M | -38.0% |
| 2018 | -$8.60M | -2.4% |
| 2017 | -$8.40M | +17.5% |
| 2017 | -$10.18M | -5.2% |
| 2017 | -$9.68M | -23.3% |
| 2017 | -$7.85M | +6.2% |
| 2016 | -$8.36M | -20.2% |
| 2016 | -$6.96M | -29.4% |
| 2016 | -$5.38M | -66.7% |
| 2016 | -$3.23M | +23.2% |
| 2015 | -$4.20M | -13.5% |
| 2014 | -$3.70M | +34.1% |
| 2013 | -$5.61M | -13988.9% |
| 2013 | -$39.8K | +99.1% |
| 2012 | -$4.68M | -13415.6% |
| 2012 | -$34.6K | -19.4% |
| 2011 | -$29.0K | -20.5% |
| 2010 | -$24.0K | -17.6% |
| 2009 | -$20.5K | -101.2% |
| 2008 | -$10.2K | -4.6% |
| 2007 | -$9.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.02M | +58.6% | -8.8% |
| June 30, 2025 | $6.60M | +126.8% | +126.6% |
| March 31, 2025 | $2.91M | -20.8% | -16.4% |
| December 31, 2024 | $3.48M | +19.9% | -8.1% |
| September 30, 2024 | $3.79M | -0.0% | +30.4% |
| June 30, 2024 | $2.91M | -48.9% | -20.8% |
| March 31, 2024 | $3.67M | +32.6% | +26.4% |
| December 31, 2023 | $2.91M | -51.1% | -23.4% |
- Bone Biologics Corp showed an increase of +54.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, Bone Biologics Corp’s stockholders equity has grown by 55407.5% (from -$9.7 thousand to $5.38 million).
- The most recent figure is from Bone Biologics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: